Unlocking New Frontiers in Triple Negative Breast Cancer Treatment: A Comprehensive Guide

Authored by renowned expert Pravin Kendrekar, “Drug and Therapy Development for Triple Negative Breast Cancer” is a groundbreaking compilation of modern diagnostic and treatment methods for this aggressive form of breast cancer.

A Timely and Authoritative Resource

This comprehensive reference book provides an in-depth exploration of contemporary approaches for treating triple negative breast cancer (TNBC), covering its molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and innovative therapies such as nanotherapeutics and photothermal therapies.

As the first comprehensive compilation of modern treatment methods for TNBC, this book is an unparalleled source of information on current and future treatment approaches, including machine learning methods for earlier detection and more accurate diagnosis.

Key Features and Insights

• A thorough introduction to HER receptors in breast cancers, providing crucial context for understanding TNBC
• Comprehensive explorations of the etiology and therapy of hormone receptor-positive breast cancer and the early-stage diagnosis of breast cancer
• The application of artificial intelligence to breast cancer diagnosis, offering new possibilities for early detection and treatment
• New insights on the role of DNA replication stress and genome instability in breast cancer, shedding light on this complex condition

This book is an indispensable resource for medicinal and pharmaceutical chemists, oncologists, and professionals working in the pharmaceutical industry or hospital settings. By staying up-to-date with the latest research and developments in TNBC treatment, readers can improve patient outcomes and advance the field of breast cancer research.

Published by Wiley on June 7, 2023, this book is available in English and features ISBN numbers 9783527351756 and 9783527841189.